ArticleHemaSphere2024

Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study.

Philipp Berning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.